I woke up to a bit of confusion. What about Dr. Lalezari? Then I saw he became interim CEO. That makes me wonder if the FDA was serious about a short term trial for HIV and Dr. Lalezari is going to shepherd us through it.
Between being a leader of his own business, extensive experience in clinical trials and his deep knowledge of leronlimab, who better. Even better make him permanent CEO then we'll have someone who gives a damn about the molecule and humanity.